HF

Health for Life Capital fund

Europe, Ile-de-France, France, Paris

Description

Health for Life Capital Fund is managed by Seventure Partners, which invests in the biotechnology and life science areas.

Investor Profile

Health for Life Capital fund has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series D, Debt Financing rounds (top funding stages).
  • Majority of deals are located in France, United States, Japan.
  • Strong thematic focus on Biotechnology, Biopharma, Health Care.

Stage Focus

  • Series B (25%)
  • Series D (25%)
  • Debt Financing (13%)
  • Series C (13%)
  • Series E (13%)
  • Series Unknown (13%)

Country Focus

  • France (50%)
  • United States (38%)
  • Japan (13%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Health Care
  • Life Science
  • Medical
  • Pharmaceutical
  • Advanced Materials
  • Agriculture
  • Food And Beverage
  • Nutrition
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Health for Life Capital fund frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 2
Closed Loop Capital
North America, Pennsylvania, United States, Radnor
Co-Investments: 1
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 7
Principia SGR
Europe, Lombardia, Italy, Milan
Co-Investments: 3
Bunge
North America, New York, United States, White Plains
Co-Investments: 1
Ajinomoto
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Nestlé Health Science
Europe, Vaud, Switzerland, Vevey
Co-Investments: 4
Continental Grain Company
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Health for Life Capital fund?

Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series DJul 21, 2021
Amount Raised: $68,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series EJun 25, 2020
Amount Raised: $51,939,777
Axial Biotherapeutics

Woburn, Massachusetts, United States

Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BFeb 27, 2019
Amount Raised: $25,000,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Debt FinancingJan 4, 2018
Amount Raised: $48,266,625
MycoTechnology

Aurora, Colorado, United States

MycoTechnology utilizes fungi-based food-processing platforms to transform the flavor and value of agricultural products.

Advanced MaterialsAgricultureBiotechnologyFood and BeverageNutritionOrganic FoodProfessional Services
Series BAug 29, 2017
Amount Raised: $42,000,000
Anaeropharma Science

Tokyo, Tokyo, Japan

Anaeropharma is a biopharmaceutical company engaged in research and development.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series UnknownJul 5, 2017
Amount Raised: $13,200,000
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series DJan 1, 2017
Amount Raised: $33,694,390
ENTEROME

Paris, Ile-de-France, France

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

BiopharmaBiotechnologyHealth CareLife Science
Series CApr 20, 2016
Amount Raised: $16,385,662